SHM Signs Letters Voicing Concerns About the Implementation of MU Stage 3
Along with other organizations, SHM signs letter to Congressional leaders in both the House and Senate stating their concerns on the implementation of Meaningful Use stage 3.
Your Browser Is No Longer Supported. Please upgrade your browser from Internet Explorer 10 to Internet Explorer 11 or higher
Along with other organizations, SHM signs letter to Congressional leaders in both the House and Senate stating their concerns on the implementation of Meaningful Use stage 3.
Along with other organizations, SHM submits letter asking that AHRQ funding be protected.
SHM sent comments to Medicare on their Measure Development Plan for MIPS and APM transition.
SHM Amicus Brief for Supreme Court Case Download Complete Amicus Brief INTRODUCTION House Bill 2 (H.B. 2), enacted in 2013, mandates that all abortion providers obtain admitting privileges at
SHM submitted comments to CMS surrounding the Medicare Access and CHIP Reauthorization Act (MACRA), that replaced the SGR and makes changes to physician payment.
SHM comments on the quality improvement section of the proposed Common Rule changes from the Office for Human Resarch Protections (OHRP)
SHM sends a letter to the Senate Health, Education, Labor and Pensions Committee in support of Scott Gottlieb, MD as Commissioner of FDA.
Along with other organizations, SHM signs on to a letter voicing concerns on provisions of the Program Integrity to the Provider Enrollment Process proposed rule.
SHM submitted comments regarding observation care and APM thresholds to the Ways and Means Health Subcommittee.
SHM submitted comments to CMS on proposed changes to the Quality Payment Program (QPP)/MACRA including facility alignment.